{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:42:46Z","timestamp":1787002966239,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T00:00:00Z","timestamp":1550534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1038\/s41409-019-0479-3","type":"journal-article","created":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T12:03:58Z","timestamp":1550577838000},"page":"1605-1613","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Safety and feasibility of outpatient autologous stem cell transplantation in pediatric patients with primary central nervous system tumors"],"prefix":"10.1038","volume":"54","author":[{"given":"Jane","family":"Koo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Nuechterlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy K.","family":"Keating","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Verneris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas K.","family":"Foreman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean M.","family":"Mulcahy Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,19]]},"reference":[{"key":"479_CR1","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/pbc.21307","volume":"50","author":"J Fangusaro","year":"2008","unstructured":"Fangusaro J, Finlay J, Sposto R, Ji L, Saly M, Zacharoulis S, et al. Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and II experience. Pediatr Blood Cancer. 2008;50:312\u20138.","journal-title":"Pediatr Blood Cancer"},{"key":"479_CR2","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/pbc.24954","volume":"61","author":"G Bergthold","year":"2014","unstructured":"Bergthold G, El Kababri M, Varlet P, Dhermain F, Sainte-Rose C, Raquin MA, et al. High-dose busulfan-thiotepa with autologous stem cell transplantation followed by posterior fossa irradiation in young children with classical or incompletely resected medulloblastoma. Pediatr Blood Cancer. 2014;61:907\u201312.","journal-title":"Pediatr Blood Cancer"},{"key":"479_CR3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/pbc.10369","volume":"42","author":"A Broniscer","year":"2004","unstructured":"Broniscer A, Nicolaides TP, Dunkel IJ, Gardner SL, Johnson J Jr., Allen JC, et al. High-dose chemotherapy with autologous stem-cell rescue in the treatment of patients with recurrent non-cerebellar primitive neuroectodermal tumors. Pediatr Blood Cancer. 2004;42:261\u20137.","journal-title":"Pediatr Blood Cancer"},{"key":"479_CR4","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s11060-007-9478-0","volume":"86","author":"DK Cheuk","year":"2008","unstructured":"Cheuk DK, Lee TL, Chiang AK, Ha SY, Chan GC. Autologous hematopoietic stem cell transplantation for high-risk brain tumors in children. J Neurooncol. 2008;86:337\u201347.","journal-title":"J Neurooncol"},{"key":"479_CR5","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1200\/JCO.1998.16.1.222","volume":"16","author":"IJ Dunkel","year":"1998","unstructured":"Dunkel IJ, Boyett JM, Yates A, Rosenblum M, Garvin JH Jr., Bostrom BC, et al. High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children\u2019s Cancer Group. J Clin Oncol. 1998;16:222\u20138.","journal-title":"J Clin Oncol"},{"key":"479_CR6","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/pbc.21032","volume":"50","author":"JR Fangusaro","year":"2008","unstructured":"Fangusaro JR, Jubran RF, Allen J, Gardner S, Dunkel IJ, Rosenblum M, et al. Brainstem primitive neuroectodermal tumors (bstPNET): results of treatment with intensive induction chemotherapy followed by consolidative chemotherapy with autologous hematopoietic cell rescue. Pediatr Blood Cancer. 2008;50:715\u20137.","journal-title":"Pediatr Blood Cancer"},{"issue":"Suppl 3","key":"479_CR7","first-page":"S1","volume":"18","author":"JL Finlay","year":"1996","unstructured":"Finlay JL. The role of high-dose chemotherapy and stem cell rescue in the treatment of malignant brain tumors. Bone Marrow Transplant. 1996;18(Suppl 3):S1\u20135.","journal-title":"Bone Marrow Transplant"},{"key":"479_CR8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/pbc.21578","volume":"51","author":"SL Gardner","year":"2008","unstructured":"Gardner SL, Asgharzadeh S, Green A, Horn B, McCowage G, Finlay J. Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors. Pediatr Blood Cancer. 2008;51:235\u201340.","journal-title":"Pediatr Blood Cancer"},{"key":"479_CR9","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1200\/JCO.1997.15.5.1814","volume":"15","author":"ML Graham","year":"1997","unstructured":"Graham ML, Herndon JE 2nd, Casey JR, Chaffee S, Ciocci GH, Krischer JP, et al. High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors. J Clin Oncol. 1997;15:1814\u201323.","journal-title":"J Clin Oncol"},{"key":"479_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1023\/B:NEON.0000021774.79094.25","volume":"67","author":"A Perez-Martinez","year":"2004","unstructured":"Perez-Martinez A, Quintero V, Vicent MG, Sevilla J, Diaz MA, Madero L. High-dose chemotherapy with autologous stem cell rescue as first line of treatment in young children with medulloblastoma and supratentorial primitive neuroectodermal tumors. J Neurooncol. 2004;67:101\u20136.","journal-title":"J Neurooncol"},{"key":"479_CR11","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1002\/cncr.23305","volume":"112","author":"CS Shih","year":"2008","unstructured":"Shih CS, Hale GA, Gronewold L, Tong X, Laningham FH, Gilger EA, et al. High-dose chemotherapy with autologous stem cell rescue for children with recurrent malignant brain tumors. Cancer . 2008;112:1345\u201353.","journal-title":"Cancer"},{"key":"479_CR12","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.4143\/crt.2015.347","volume":"48","author":"KW Sung","year":"2016","unstructured":"Sung KW, Lim DH, Yi ES, Choi YB, Lee JW, Yoo KH, et al. Tandem high-dose chemotherapy and autologous stem cell transplantation for atypical teratoid\/rhabdoid tumor. Cancer Res Treat. 2016;48:1408\u201319.","journal-title":"Cancer Res Treat"},{"key":"479_CR13","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/pbc.21064","volume":"48","author":"KW Sung","year":"2007","unstructured":"Sung KW, Yoo KH, Cho EJ, Koo HH, Lim DH, Shin HJ, et al. High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor. Pediatr Blood Cancer. 2007;48:408\u201315.","journal-title":"Pediatr Blood Cancer"},{"issue":"Suppl 2","key":"479_CR14","doi-asserted-by":"publisher","first-page":"S104","DOI":"10.1038\/bmt.2008.66","volume":"41","author":"E Castagnola","year":"2008","unstructured":"Castagnola E, Faraci M, Moroni C, Bandettini R, Caruso S, Bagnasco F, et al. Bacteremias in children receiving hemopoietic SCT. Bone Marrow Transplant. 2008;41(Suppl 2):S104\u20136.","journal-title":"Bone Marrow Transplant"},{"key":"479_CR15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/sj.bmt.1702109","volume":"25","author":"CA Mullen","year":"2000","unstructured":"Mullen CA, Nair J, Sandesh S, Chan KW. Fever and neutropenia in pediatric hematopoietic stem cell transplant patients. Bone Marrow Transplant. 2000;25:59\u201365.","journal-title":"Bone Marrow Transplant"},{"key":"479_CR16","doi-asserted-by":"publisher","first-page":"e0162178","DOI":"10.1371\/journal.pone.0162178","volume":"11","author":"YB Choi","year":"2016","unstructured":"Choi YB, Yi ES, Kang JM, Lee JW, Yoo KH, Kim YJ, et al. Infectious complications during tandem high-dose chemotherapy and autologous stem cell transplantation for children with high-risk or recurrent solid tumors. PLoS One. 2016;11:e0162178.","journal-title":"PLoS One"},{"key":"479_CR17","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/tid.12165","volume":"16","author":"A Srinivasan","year":"2014","unstructured":"Srinivasan A, McLaughlin L, Wang C, Srivastava DK, Shook DR, Leung W, et al. Early infections after autologous hematopoietic stem cell transplantation in children and adolescents: the St. Jude experience. Transpl Infect Dis. 2014;16:90\u20137.","journal-title":"Transpl Infect Dis"},{"key":"479_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s12185-016-2113-0","volume":"105","author":"W Choeyprasert","year":"2017","unstructured":"Choeyprasert W, Hongeng S, Anurathapan U, Pakakasama S. Bacteremia during neutropenic episodes in children undergoing hematopoietic stem cell transplantation with ciprofloxacin and penicillin prophylaxis. Int J Hematol. 2017;105:213\u201320.","journal-title":"Int J Hematol"},{"key":"479_CR19","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.amjsurg.2012.02.023","volume":"205","author":"RH Brown","year":"2013","unstructured":"Brown RH, Subramanian A, Hwang CS, Chang S, Awad SS. Comparison of infectious complications with synthetic mesh in ventral hernia repair. Am J Surg. 2013;205:182\u20137.","journal-title":"Am J Surg"},{"key":"479_CR20","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1038\/bmt.2017.77","volume":"52","author":"MB Abid","year":"2017","unstructured":"Abid MB, Christopher D, Abid MA, Poon ML, Tan LK, Koh LP, et al. Safety and cost-effectiveness of outpatient autologous transplantation for multiple myeloma in Asia: single-center perspective from Singapore. Bone Marrow Transplant. 2017;52:1044\u20136.","journal-title":"Bone Marrow Transplant"},{"key":"479_CR21","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/bmt.2015.46","volume":"50","author":"TM Graff","year":"2015","unstructured":"Graff TM, Singavi AK, Schmidt W, Eastwood D, Drobyski WR, Horowitz M, et al. Safety of outpatient autologous hematopoietic cell transplantation for multiple myeloma and lymphoma. Bone Marrow Transplant. 2015;50:947\u201353.","journal-title":"Bone Marrow Transplant"},{"key":"479_CR22","doi-asserted-by":"crossref","unstructured":"Martino M, Lemoli RM, Girmenia C, Castagna L, Bruno B, Cavallo F, et al. Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma. Bone Marrow Transplant. 2016;51:1032\u201340.","DOI":"10.1038\/bmt.2016.79"},{"key":"479_CR23","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/bmt.2009.234","volume":"45","author":"SR Solomon","year":"2010","unstructured":"Solomon SR, Matthews RH, Barreras AM, Bashey A, Manion KL, McNatt K, et al. Outpatient myeloablative allo-SCT: a comprehensive approach yields decreased hospital utilization and low TRM. Bone Marrow Transplant. 2010;45:468\u201375.","journal-title":"Bone Marrow Transplant"},{"key":"479_CR24","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.mayocp.2017.09.012","volume":"93","author":"MA Gertz","year":"2018","unstructured":"Gertz MA, Buadi FK, Hayman SR, Lacy MQ, Dispenzieri A, Dingli D, et al. Safety outcomes for autologous stem cell transplant in multiple myeloma. Mayo Clin Proc. 2018;93:56\u20138.","journal-title":"Mayo Clin Proc"},{"key":"479_CR25","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.bbmt.2017.09.021","volume":"24","author":"M Martino","year":"2018","unstructured":"Martino M, Ciavarella S, De Summa S, Russo L, Meliambro N, Imbalzano L, et al. A comparative assessment of quality of life in patients with multiple myeloma undergoing autologous stem cell transplantation through an outpatient and inpatient model. Biol Blood Marrow Transplant. 2018;24:608\u201313.","journal-title":"Biol Blood Marrow Transplant"},{"key":"479_CR26","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.clml.2017.05.018","volume":"17","author":"M Martino","year":"2017","unstructured":"Martino M, Console G, Russo L, Meliado A, Meliambro N, Moscato T, et al. Autologous stem cell transplantation in patients with multiple myeloma: an activity-based costing analysis, comparing a total inpatient model versus an early discharge model. Clin Lymphoma Myeloma Leuk. 2017;17:506\u201312.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"479_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.pediatrneurol.2015.03.019","volume":"53","author":"BH Cohen","year":"2015","unstructured":"Cohen BH, Geyer JR, Miller DC, Curran JG, Zhou T, Holmes E, et al. Pilot study of intensive chemotherapy with peripheral hematopoietic cell support for children less than 3 years of age with malignant brain tumors, the CCG-99703 Phase I\/II Study. A report from the Children\u2019s Oncology Group. Pediatr Neurol. 2015;53:31\u201346.","journal-title":"Pediatr Neurol"},{"key":"479_CR28","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","volume":"36","author":"TC Horan","year":"2008","unstructured":"Horan TC, Andrus M, Dudeck MA. CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309\u201332.","journal-title":"Am J Infect Control"},{"key":"479_CR29","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0755-4982(04)98636-8","volume":"33","author":"M Rovira","year":"2004","unstructured":"Rovira M. Outpatient management of autologous haematopoietic cell transplantation: the Barcelona experience. Presse Med. 2004;33:479\u201381.","journal-title":"Presse Med"},{"issue":"4 Suppl 7","key":"479_CR30","first-page":"25","volume":"21","author":"WP Peters","year":"1994","unstructured":"Peters WP, Ross M, Vredenburgh JJ, Hussein A, Rubin P, Dukelow K, et al. The use of intensive clinic support to permit outpatient autologous bone marrow transplantation for breast cancer. Semin Oncol. 1994;21(4 Suppl 7):25\u201331.","journal-title":"Semin Oncol"},{"key":"479_CR31","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s00277-006-0149-6","volume":"85","author":"C Leger","year":"2006","unstructured":"Leger C, Sabloff M, McDiarmid S, Bence-Bruckler I, Atkins H, Bredeson C, et al. Outpatient autologous hematopoietic stem cell transplantation for patients with relapsed follicular lymphoma. Ann Hematol. 2006;85:723\u20139.","journal-title":"Ann Hematol"},{"key":"479_CR32","doi-asserted-by":"publisher","first-page":"4855","DOI":"10.1200\/JCO.2006.06.4238","volume":"24","author":"F Fernandez-Aviles","year":"2006","unstructured":"Fernandez-Aviles F, Carreras E, Urbano-Ispizua A, Rovira M, Martinez C, Gaya A, et al. Case-control comparison of at-home to total hospital care for autologous stem-cell transplantation for hematologic malignancies. J Clin Oncol. 2006;24:4855\u201361.","journal-title":"J Clin Oncol"},{"key":"479_CR33","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1086\/318715","volume":"32","author":"PH Chandrasekar","year":"2001","unstructured":"Chandrasekar PH, Abraham OC, Klein J, Alangaden G, Chalasani G, Cassells L, et al. Low infectious morbidity after intensive chemotherapy and autologous peripheral blood progenitor cell transplantation in the outpatient setting for women with breast cancer. Clin Infect Dis. 2001;32:546\u201351.","journal-title":"Clin Infect Dis"},{"key":"479_CR34","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.bbmt.2012.12.006","volume":"19","author":"A Holbro","year":"2013","unstructured":"Holbro A, Ahmad I, Cohen S, Roy J, Lachance S, Chagnon M, et al. Safety and cost-effectiveness of outpatient autologous stem cell transplantation in patients with multiple myeloma. Biol Blood Marrow Transplant. 2013;19:547\u201351.","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0479-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0479-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0479-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:14:13Z","timestamp":1684602853000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-019-0479-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,19]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["479"],"URL":"https:\/\/doi.org\/10.1038\/s41409-019-0479-3","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,19]]},"assertion":[{"value":"7 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}